Cardiovascular Risk in Type 2 Diabetes Mellitus: Assessment and Control

by Nicolae Hancu (Editor)

Overview

A lot of time has been spent trying to convince health care providers and policy makers of the enormous importance of macrovascular disease in persons with type 2 diabetes. In this volume, we present facts that dem­ onstrate how important it is to recognize macrovascular disease in these patients in daily practice. This volume has been compiled to help those already involved in dia­ betes care, to be more involved in cardiovascular risk control, a task that is not easily achieved. The area of cardiovascular risk in type 2 diabetes is heterogeneous. Trying to characterize it, we can only say: certainly we know more than we do, but for sure we do less than we could. Our challenge is to change this. Nicolae Htmcu Professor N. Hancu was born in Romania in 1940. He studied medicine at the Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, and obtained his speciality in internal medicine in 1970, and in diabetes, nutrition and metabolic disease in 1986. He was appointed Professor and Head of the Department of Diabetes, Nutrition and Metabolic Diseases of the same university in 1993. He has been a full member of the Romanian Academy of Medical Sciences since 1995. Professor Hancu's major interest is related to clinical lipidology, visceral obesity, and cardiovascular risk in type 2 diabetes. He has published over 200 papers and 14 books in this area. He has been invited as Visiting Professor at many universities in Madrid, Valladolid, Barcelona, and Los Angeles.

Product Details

ISBN-13:	9783642593529
Publisher:	Springer-Verlag New York, LLC
Publication date:	12/06/2012
Sold by:	Barnes & Noble
Format:	eBook
File size:	7 MB

Table of Contents

1 The Heavy Burden of Cardiovascular Disease in Type 2 Diabetes M. Laakso.- 2 Atherogenesis in Diabetes D. Dabelea.- 3 Hyperglycaemia as Cardiovascular Risk in Type 2 Diabetes P. Brunetti, G. Perriello.- 4 Gliclazide and Diabetic Angiopathy A.J. Weekes.- 5 Clinical Experience with Repaglinide, the First Prandial Glucose Regulator in Type 2 Diabetes K. Brown Frandsen.- 6 Effects of Metformin on Glycaemic Control and Cardiovascular Risk in Type 2 Diabetes G. Perriello.- 7 Dyslipidemia and Cardiovascular Risk in Diabetes R. Carmena, J.F. Ascaso.- 8 Hypertension in Type 2 Diabetes Mellitus M. Serrano Rios, M.T. Martinez Larad.- 9 Microalbuminuria and Cardiovascular Disease in Type 2 Diabetes M. Massi Benedetti, M. Orsini Federici.- 10 Cardiovascular Risk in Obese Type 2 Diabetes Mellitus Patients G. Roman, X. Formiguera, N. Hâncu.- 11 The Hypertriglyceridemic Waist Concept: Implication for Evaluation and Management of Cardiovascular Disease Risk in Type 2 Diabetes I. Lemieux, J.-P. Després.- 12 Oxidative Stress and Cardiovascular Risk in Type 2 Diabetes A. Ceriello.- 13 Lifestyle and Cardiovascular Risk in Type 2 Diabetes M.W. Conard, W.S. Carlos Poston.- 14 The Prothrombotic Syndrome in Type 2 Diabetes: Assessment and Control M. Cucuianu, M. Coca.- 15 Hyperhomocysteinemia as Cardiovascular Risk Factor in Type 2 Diabetes Mellitus A. de Leiva.- 16 Cardiac Autonomic Neuropathy: Is it a Cardiovascular Risk Factor in Type 2 Diabetes? P. Kempler.- 17 Thiazolidinediones in Cardiovascular Risk in Type 2 Diabetes Mellitus M. Khamaisi, L. Symmer, I. Raz.- 18 Hyperglycemia and Cardiovascular Disease in Type 2 Diabetes Mellitus: Evidence-based Approach to Primary and Secondary Prevention Z. Milicevic, N. Hâncu, I. Raz.- 19 Cardiac Exploration of Diabetic Patients R. C?pâlneanu.-20 Assessment of Peripheral Vascular Disease I.A. Veresiu.- 21 Global Approach to Cardiovascular Risk in Type 2 Diabetic Persons N. Hâncu, A. Cerghizan.